Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

CUSIP: 03843E104

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
120,192,308
Total 13F shares
72,195,502
Share change
+4,942,091
Total reported value
$466,240,119
Put/Call ratio
139%
Price per share
$6.46
Number of holders
176
Value change
+$33,959,561
Number of buys
111
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q4 2025

As of 31 Dec 2025, Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by 176 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 72,195,502 shares. The largest 10 holders included Bratton Capital Management, L.P., BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC, EcoR1 Capital, LLC, SAMSARA BIOCAPITAL, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, FEDERATED HERMES, INC., and MORGAN STANLEY. This page lists 176 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.